BCL6 inhibitor 14

CAS No.

BCL6 inhibitor 14 ( —— )

Catalog No. M17101 CAS No.

BCL6 inhibitor 14 is a potent BCL-6 inhibitor with FRET IC50 of 63 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BCL6 inhibitor 14
  • Note
    Research use only, not for human use.
  • Brief Description
    BCL6 inhibitor 14 is a potent BCL-6 inhibitor with FRET IC50 of 63 nM.
  • Description
    BCL6 inhibitor 14 is a potent BCL-6 inhibitor with FRET IC50 of 63 nM.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Bcl-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    --
  • Formula Weight
    573.14
  • Molecular Formula
    C29H41ClN6O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (R)-25-chloro-41-methyl-14-(4-methylpentanoyl)-41,42,43,44-tetrahydro-5,8-dioxa-3-aza-4(6,8)-quinolina-2(2,4)-pyrimidina-1(1,2)-piperazinacyclononaphan-42-one compound with ethane (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. McCoull W, et al. ACS Chem Biol. 2018 Oct 17. doi: 10.1021/acschembio.8b00698.
molnova catalog
related products
  • AMG-176

    AMG-176 (AMG176) is a novel, potent and selective Mcl-1 inhibitor that binds with high affinity and selectivity to the BH3-binding groove of Mcl-1.

  • SW063058

    SW063058 is a small molecule that selectively disrupt Beclin 1/Bcl-2 binding as compared to Bax/Bcl-2 and Bim/Bcl-2 binding and induces autophagic flux at concentrations with minimal cytotoxicity.

  • Lisaftoclax

    Bcl-2/Bcl-xl inhibitor 1 is a dual Bcl-2 and Bcl-xl inhibitor (IC50s: 2 nM and 5.9 nM for Bcl-2 and Bcl-xl) with anti-tumor activity. It is extracted from patent WO2018027097A1.